Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anorexia × EOM613 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1 Neoplasms 1 Fatigue 1 Anorexia 1

Interventions

Megestrol Acetate 4 Mirtazapine 3 nabiximols 1 anamorelin 1 Watchful Waiting 1 Thalidomide 1 Olanzapine 1 Observation 1 Megestrol 1 Infliximab 1 Gemcitabine 1 Flurandrenolone 1 EOM613 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01206335 2012-11-27

Open Label Study With OHR/AVR118 in Advanced Cancer Patients With Anorexia-Cachexia

Ohr Pharmaceutical Inc.

Phase 2 Unknown

Anorexia, Fatigue, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡